Sadako Nakamura

Dr. Sadako Nakamura

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
KTKenichi Tanabe
Kenichi Tanabe
AOAsuka Okuda
Asuka Okuda
FKFukami Ken
Fukami Ken
NYNatsumi Yamanaka
Natsumi Yamanaka
SNSadako Nakamura
Sadako Nakamura
TOTsuneyuki Oku
Tsuneyuki Oku
Maltobionic acid (MA), formed by a gluconic acid and glucose linked by an α‐1,4 bond, may have the properties of a nondigestible oligosaccharide. The objective of this study was to elucidate the bioavailability of MA in rats and humans by observing digestion of MA by small intestinal enzymes, the fermentation of MA by gut microbiota, and the effect of adaptation following prolonged ingestion of MA. MA digestion was assessed using brush border membrane vesicles (BBMV) from rat small intestine. A within‐subject repeated measures design was used for ingestion experiments in 10 healthy female participants. After MA ingestion, postprandial plasma glucose and insulin levels, breath hydrogen excretion, and urinary MA were measured. The effect of adaptation following prolonged MA ingestion was investigated in rats. MA was minimally hydrolyzed by BBMV. Ingestion of 10 g of MA by healthy females did not elevate postprandial plasma glucose and insulin levels. Breath hydrogen and urinary MA were negligibly excreted over 8 hr following ingestion. Adaptation to prolonged MA ingestion produced no significant difference in exhaled hydrogen levels over 8 hr following administration compared with controls. MA is a new food material that is highly resistant to digestion and fermentation. It expresses the characteristics of a nondigestible oligosaccharide, including being low energy, improving the flavor of food and juice, and mineral solubilization.


1 August 2011 in Current Nutrition & Food Science
Verified
Journal Article
Closed access
PDF file
KTKenichi Tanabe
Kenichi Tanabe
SNSadako Nakamura
Sadako Nakamura
TOTsuneyuki Oku
Tsuneyuki Oku
The enzymatic-HPLC quantitative method is widely used for the determination of non-digestible oligosaccharide. However, the results obtained from the method are inconsistent with some reports. In the present study, we clarified the reason that the existent enzymatic-HPLC method could not accurately measure the quantity of non-digestible oligosaccharide, and then we developed the improved enzymatic-HPLC method for accurate quantification of non-digestible oligosaccharide. When some digestible and non-digestible oligosaccharides were measured by the existent enzymatic-HPLC method, 67% of isomaltooligosaccharide (IMO) was recovered as intact form, and 91% of sucrose and 95% of lactose were recovered as intact form, respectively. This result is questionable because IMO, sucrose and lactose were clearly measured as non-digestible oligosaccharides in this method. However, IMO was readily hydrolyzed and the intact form was not detected by the improved enzymatic-HPLC method which pig small intestinal enzymes were added to the hydrolyzing process in the existent enzymatic-HPLC method. Also, sucrose and lactose were completely hydrolyzed and the intact form were not recovered. The recovery rates of intact fructooligosaccharide (FOS) and resistant maltodextrin (RMD), which are not digested by small intestinal disaccharidase, were 92.1% and 78.8%, respectively. The contradiction appears to demonstrate that thermostable α-amylase and amyloglucosidase may not be able to hydrolyze the low molecular weight oligosaccharides, although they can hydrolyze spontaneously high molecular polysaccharides. In conclusion, the present study strongly suggests that the existent enzymatic-HPLC quantitative method cannot accurately measure non-digestible oligosaccharides, and that the improved enzymatic-HPLC method is suitable for the quantity of oligosaccharides.

5 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KTKenichi Tanabe
Kenichi Tanabe
ITIkuma Tanaka
Ikuma Tanaka
HHHiromi Hayashi
Hiromi Hayashi
KYKazuhiro Yoshinaga
Kazuhiro Yoshinaga
SNSadako Nakamura
Sadako Nakamura
Background/Objectives: We hypothesized that orally ingested 1,5-anhydro-D-mannitol (AM) would be absorbed from the gut but poorly metabolized, and it may have low fermentability by gut microbiota based on the breath hydrogen test. Methods: We used a dual-model approach in this study. In animal experiments, AM was administered orally to male Wistar rats. In a randomized, three-way crossover trial (UMIN000054040), 15 healthy young adults consumed a single 5 g dose of AM, mannose, or fructooligosaccharide (FOS). Primary outcome was breath hydrogen concentrations; secondary outcomes included plasma AM, blood glucose concentration, and urinary AM excretion. Results: After ingestion of 5 g AM in humans, the 14 h area under the curve for breath hydrogen excretion was markedly lower after AM than that after FOS ingestion (p < 0.05). Plasma AM peaked at 1 h, whereas blood glucose remained unchanged from baseline. Approximately 30% of ingested AM was excreted unchanged in urine within 24 h. Results of animal experiments were similar to those in humans. Fecal excretion in AM was confirmed to be minimal, accounting for ~1% of the administered dose within 24 h in rats. Conclusions: These findings indicate that AM is potentially a low-energy carbohydrate.